Allurion Technologies Inc... (ALUR)
NYSE: ALUR
· Real-Time Price · USD
2.12
-0.04 (-1.85%)
At close: Sep 24, 2025, 3:57 PM
2.16
2.13%
After-hours: Sep 24, 2025, 06:25 PM EDT
-1.85% (1D)
| Bid | 2.1 |
| Market Cap | 16.42M |
| Revenue (ttm) | 19.92M |
| Net Income (ttm) | -31.53M |
| EPS (ttm) | -10.13 |
| PE Ratio (ttm) | -0.21 |
| Forward PE | -0.54 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 2.12 |
| Volume | 15,005 |
| Avg. Volume (20D) | 105,209 |
| Open | 2.15 |
| Previous Close | 2.16 |
| Day's Range | 2.11 - 2.18 |
| 52-Week Range | 1.98 - 20.00 |
| Beta | -0.50 |
| Ex-Dividend Date | n/a |
About ALUR
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ALUR
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ALUR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsAllurion Technologies Inc. is scheduled to release its earnings on
Nov 12, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
+10.42%
Allurion Technologies shares are trading higher af...
Unlock content with
Pro Subscription
4 months ago
-0.36%
Allurion Technologies shares are trading higher after the company announced the presentation of a study entitled "The Swallowable Gastric Balloon Program with AI Powered Health Coach Leads to Metabolically Healthy Weight Loss in French Patients," that assessed 1,962 patients in France treated with the Allurion Program.
1 month ago · seekingalpha.com
Allurion Technologies Inc. (ALUR) Q2 2025 Earnings Call TranscriptAllurion Technologies Inc. (NYSE:ALUR ) Q2 2025 Earnings Conference Call August 13, 2025 8:30 AM ET Company Participants Shantanu K. Gaur - Co-Founder, CEO, President, Principal Financial & Accounting...
